VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1548450
Sex: F
Age: 79
State: TN

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Rash at injection site; Arm black/blue; Swelling from shoulder to elbow at the injection site; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE BRUISING (Arm black/blue), VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site) and VACCINATION SITE RASH (Rash at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The patient's past medical history included Anemia. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 10-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Arm black/blue) and VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site). On 11-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On 10-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. At the time of the report, VACCINATION SITE BRUISING (Arm black/blue), VACCINATION SITE SWELLING (Swelling from shoulder to elbow at the injection site) and VACCINATION SITE RASH (Rash at injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1548451
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Body ache; Vomiting; Fever; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Crohn's disease and Osteoarthritis. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness: Crohn's disease; Osteoarthritis

ID: 1548452
Sex: F
Age: 67
State: MO

Vax Date: 01/19/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: I had some itching, too; My arm at the injection site is still tender; Hurts when you touch it; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K201A and 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it). At the time of the report, PRURITUS (I had some itching, too), VACCINATION SITE PAIN (My arm at the injection site is still tender) and VACCINATION SITE PAIN (Hurts when you touch it) outcome was unknown.

Other Meds:

Current Illness:

ID: 1548453
Sex: F
Age: 19
State: CT

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Chills; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548454
Sex: F
Age: 38
State: NY

Vax Date: 01/05/2021
Onset Date: 02/02/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body aches; My left hand was going numb, my legs were going numb on and off; Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total; Chills; Fever below 104 F; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN (Body aches), HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off), VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total), CHILLS (Chills) and PYREXIA (Fever below 104 F) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 039K20A) for COVID-19 vaccination. No Medical History information was given by the reporter. Concomitant products included METOPROLOL for an unknown indication. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 02-Feb-2021, the patient experienced PAIN (Body aches), HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off), VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total), CHILLS (Chills) and PYREXIA (Fever below 104 F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-Feb-2021, VOMITING (Vomiting every half an hour for 12 hs, then it went to 1 hour, and 24 hs passed in total) had resolved. On 04-Feb-2021, PYREXIA (Fever below 104 F) had resolved. On 05-Feb-2021, PAIN (Body aches) had resolved. On 06-Feb-2021, HYPOAESTHESIA (My left hand was going numb, my legs were going numb on and off) and CHILLS (Chills) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Pyrexia: 104 f (Inconclusive) Inconclusive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the events was not applicable. This case was linked to MOD-2021-056957 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The follow up received on 26-APR-2021. No New Information is added(NNI).

Other Meds: METOPROLOL

Current Illness:

ID: 1548455
Sex: F
Age:
State: TX

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever 101; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PYREXIA (Fever 101). At the time of the report, PYREXIA (Fever 101) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Pyrexia: 101 Inconclusive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548456
Sex: M
Age: 77
State: CA

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: missed second dose; a rash starting from his back that spread to his whole body; it is still itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it is still itching), PRODUCT DOSE OMISSION ISSUE (missed second dose) and RASH (a rash starting from his back that spread to his whole body) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S) from 11-Jan-2021 to an unknown date for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PRURITUS (it is still itching) and RASH (a rash starting from his back that spread to his whole body). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed second dose). The patient was treated with TRIAMCINOLONE for Itch, at a dose of 1 dosage form. At the time of the report, PRURITUS (it is still itching), PRODUCT DOSE OMISSION ISSUE (missed second dose) and RASH (a rash starting from his back that spread to his whole body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details also included Benadryl. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Significant follow-up received on 23-Jun-2021 where events has been updated as Remanence of rash and Missed second dose

Other Meds: PLAQUENIL S

Current Illness:

ID: 1548457
Sex: F
Age: 78
State: CA

Vax Date: 02/04/2021
Onset Date: 02/07/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: tightness in the throat; facial swelling; hives/very small hives on the trunk; lip swelled; lost her voice; A spontaneous report was received from a consumer (patient's daughter), concerning a 73-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tightness in the throat, facial swelling (swelling face), hives/very small hives on the trunk (urticaria), lip swelled (lip swelling), and lost her voice (aphonia). The patient's medical history was not provided. Concomitant product use was not provided. On 04 Feb 2021, about 40 hours prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (batch number: 041L20A ) intramuscularly for the prophylaxis of COVID-19 infection. On 7 Feb 2021, 40 hours later, the patient experienced hives, facial swelling, and tightness in the throat. The reaction started with very small hives on trunk, face and lip swelled, and she lost her voice. The daughter reported that events worsened at night. The reporter's sister took the patient to the emergency room, where she was treated with saline, steroids and diphenhydramine. The patient was still taking the diphenhydramine and steroids. The daughter said they were going to have more specific allergy tests done on the patient. Action taken with mRNA-1273 in response to the event was unknown. It was noted that the patient was reluctant to have the second dose. The outcome of the events of tightness in the throat, facial swelling, hives/very small hives on the trunk, lip swelled, and lost her voice was unknown.

Other Meds:

Current Illness:

ID: 1548458
Sex: F
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548459
Sex: F
Age: 79
State: TN

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Hot; Itchy; It went from bright red to pink; Sore; A pink rash, t grew and grew, about day 6-7-8-9 it was a; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink), RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a) and PAIN IN EXTREMITY (Sore) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. Concomitant products included AMLODIPINE and LISINOPRIL for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a). On 10-Feb-2021, the patient experienced FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink) and PAIN IN EXTREMITY (Sore). At the time of the report, FEELING HOT (Hot), PRURITUS (Itchy), SKIN DISCOLOURATION (It went from bright red to pink) and PAIN IN EXTREMITY (Sore) outcome was unknown and RASH (A pink rash, t grew and grew, about day 6-7-8-9 it was a) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: AMLODIPINE; LISINOPRIL

Current Illness:

ID: 1548460
Sex: F
Age: 69
State: OH

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Chills; Heaviness with breathing; Extreme sweating; body aches and pain; felt like organs was being shifted and squeezed.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.). At the time of the report, CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1548461
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 02/14/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Itchy all over his body; Shivering; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), PRURITUS (Itchy all over his body) and CHILLS (Shivering) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PRURITUS (Itchy) and CHILLS (Shivering). On an unknown date, the patient experienced PRURITUS (Itchy all over his body). On 16-Feb-2021, PRURITUS (Itchy) and CHILLS (Shivering) had resolved. At the time of the report, PRURITUS (Itchy all over his body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548462
Sex: F
Age: 45
State: NJ

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: arm went numb immediately; extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger). At the time of the report, VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. treatment information was not provided concomitant drugs were not reported Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: fallow up received on 27-APR-2021 patient refused for fallow up

Other Meds:

Current Illness:

ID: 1548463
Sex: F
Age: 70
State: NY

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Reactions after her vaccination; felt like my eyes were heavy; Felt fuzzy in the head, foggy and not connecting the dots; Transient Global Amnesia(TGA); After 11:15 I had no memory of what I was doing until 17:00; It felt like I was in a dream but couldn't say what the dream was about; My wife said my conversations made no sense; headache; nausea; Vomiting; dissociation, disassociate; Soreness at the injections site; A spontaneous report was received from a consumer concerning a 70-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced reactions after her vaccination, soreness at the injections site, she was reaching for pepper yet she was unable to call it pepper in her mind, dissociation, After 11:15 I had no memory of what I was doing until 17:00(Amnesia), My wife said my conversations made no sense(Slurry speech)), it felt like I was in a dream but couldn't say what the dream was about(Dreamy state), didn't know the day, year or what we ate the day before, headache, nausea, vomiting, felt fuzzy in the head, transient global amnesia (TGA)with seriousness criteria as hospitalization required, foggy and not connecting the dots, disassociated and felt like my eyes were heavy. The patient's medical history was not provided by the reporter. Concomitant medications reported included cetirizine hydrochloride, fluticasone propionate, famipril, carvedilol, alendronate sodium, levothyroxine, vitamin D3, ascorbic acid, calcium, magnesium, zinc combo pill and probiotics. On 09 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 030M20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection. On an unspecified date, patient experienced reactions after her vaccination. On 09 Feb 2021, patient experienced soreness at the injections site. On 12 Feb 2021, patient experienced she was reaching for pepper yet she was unable to call it pepper in her mind and dissociation (happened twice on 13 Feb 2021 and 14 Feb 2021). On 14 Feb 2021, patient experienced after 11:15 she had no memory of what she was doing until 17:00, my wife said my conversations made no sense, it felt like I was in a dream but couldn't say what the dream was about, didn't know the day, year or what we ate the day before, headache, nausea, vomiting, felt fuzzy in the head. The ambulance took her to the south shore university hospital emergency room, and was diagnosed with transient global amnesia (TGA), she was admitted overnight for observation. She was foggy and not connecting the dots, disassociated. By 20:00 she was back to normal. There was no medication and they were pleased with the progress of her being able to recall the situation. On 18 Feb 2021, patient experienced felt like her eyes were heavy. She will be scheduled to consult a pulmonologist but that appointment was pending. Her primary care practitioner was concerned as that was related to the Moderna COVID-19 vaccination and is skeptical to let her take second dose. She has an appointment with a neurologist for 01 Mar 2021. On an unspecified date, lab tests were performed included tests for tumor, stroke, seizure or vascular issues, MRI and EEG; however, the results were negative. Treatment for the events were not provided by the reporter. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event, reactions after her vaccination was unknown. The outcome of the event, soreness at the injections site was recovered on 10 Feb 2021. The outcome of the events she was reaching for pepper yet she was unable to call it pepper in her mind was resolved on 12 Feb 2021, The outcome of the event dissociation were recovered on 13 Feb 2021. The outcome of the events after 11:15 I had no memory of what I was doing until 17:00, my wife said my conversations made no sense, it felt like I was in a dream but couldn't say what the dream was about, didn't know the day, year or what we ate the day before, headache, nausea, vomiting, felt fuzzy in the head, transient global amnesia (TGA), foggy and not connecting the dots, disassociated were recovered on 14 Feb 2021. The outcome of the event felt like my eyes were heavy was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events (nausea, vomiting, headache, and vaccination site pain) a causal relationship cannot be excluded. Very limited information regarding these event (Transient global amnesia and other events) has been provided at this time. Further information has been requested.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE ALLERGY RELIEF; RAMIPRIL; COREG; FOSAMAX; LEVOTHYROXINE; VITAMIN D3; VITAMIN C ACID; CALCIUM + MAGNESIUM + ZINK; PROBIOTICS NOS

Current Illness:

ID: 1548464
Sex: M
Age: 81
State: NC

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (General discomfort), PAIN (pain in the site), NAUSEA (not sick, don't feel nauseated), ILLNESS (just don't feel well.) and ARTHRALGIA (sore shoulder). At the time of the report, DISCOMFORT (General discomfort), PAIN (pain in the site), NAUSEA (not sick, don't feel nauseated), ILLNESS (just don't feel well.) and ARTHRALGIA (sore shoulder) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548465
Sex: F
Age: 69
State: NY

Vax Date: 01/21/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Body aches; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 22-Feb-2021, PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) had resolved. No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Outcome of the events updated. Duration of the event added as 5 days.

Other Meds:

Current Illness:

ID: 1548466
Sex: F
Age: 81
State: CO

Vax Date: 01/22/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Abscess on bottom; Sore spot on bottom; This spontaneous case was reported by a consumer and describes the occurrence of ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20a) for COVID-19 vaccination. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom). At the time of the report, ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: TYLENOL

Current Illness:

ID: 1548467
Sex: F
Age: 48
State: NC

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: drop in blood sugar level; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGLYCAEMIA (drop in blood sugar level) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOGLYCAEMIA (drop in blood sugar level). At the time of the report, HYPOGLYCAEMIA (drop in blood sugar level) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medication information was provided. No treatment medication were provided. The patient did not report any adverse reactions after the second dose. Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Added dose 2 details.

Other Meds:

Current Illness: Diabetes mellitus

ID: 1548468
Sex: F
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Diarrhea; cracking neck/pain in neck; Pain in right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder). At the time of the report, DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant drugs were reported. No treatment medications were reported. This case was linked to MOD-2021-024627 (Dose 2 case) (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Telephone Contact Report received and event onset dates and outcomes were updated.

Other Meds:

Current Illness:

ID: 1548469
Sex: M
Age: 66
State:

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Arm tightness; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm tightness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concurrent medical conditions included Migraine. Concomitant products included AMLODIPINE, LOSARTAN POTASSIUM (COZARIL), ROSUVASTATIN CALCIUM (CRESTOR), OMEPRAZOLE (OPRIL [OMEPRAZOLE]), TAMSULOSIN, TOPIRAMATE (TOPAMAX), TRAZODONE and EZETIMIBE (ZETIA) for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm tightness). At the time of the report, LIMB DISCOMFORT (Arm tightness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: AMLODIPINE; COZARIL; CRESTOR; OPRIL [OMEPRAZOLE]; TAMSULOSIN; TOPAMAX; TRAZODONE; ZETIA

Current Illness:

ID: 1548470
Sex: F
Age: 33
State: SC

Vax Date: 02/10/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Passed out for about one minute; Vomiting; Chills; Sweat; Decreased appetite; Mild fever/Higher fever; Sore arm; Nauseated; A spontaneous report, was received from a health care professional (patient's husband), concerning a 33-year-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine, and experienced passed out for about one minute (loss of consciousness), sore arm (pain in extremity), sweat (hyperhidrosis), decreased appetite, mild fever/higher fever (pyrexia), chills, vomiting, and nauseated (nausea). The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination. On 10 Feb 2021, prior to the onset of events, the patient received their second planned dose of mRNA-1273 (lot number: 038K20), intramuscularly into left upper arm for the prophylaxis of COVID-19 infection. On 10 Feb 2021, after the second dose of vaccine, the patient experienced sore arm, and mild fever/higher fever. On 11 Feb 2021, the patient developed chills, sweat, and decreased appetite. The patient has passed out for about a minute and started vomiting on 12 Feb 2021. The patient did not seek any medical emergency. The patient was nauseated on an unknown date in Feb 2021. The patient received treatment medication with ibuprofen twice within 12 hours of adverse events apart. The patient was currently not taking any other medications. The outcome for the events, passed out for about one-minute, sore arm, sweat, decreased appetite, mild fever/higher fever, chills, vomiting, and nauseate, were reported as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1548471
Sex: M
Age:
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Body aches; Fever; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1548472
Sex: F
Age: 59
State: NC

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Rash 3-4 times larger than the injection site, lumpy rash; Itchy near injection site; Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort), VACCINATION SITE PRURITUS (Itchy near injection site) and RASH (Rash 3-4 times larger than the injection site, lumpy rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DISCOMFORT (Discomfort). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy near injection site). On 18-Feb-2021, the patient experienced RASH (Rash 3-4 times larger than the injection site, lumpy rash). On 12-Feb-2021, DISCOMFORT (Discomfort) had resolved. On 18-Feb-2021, VACCINATION SITE PRURITUS (Itchy near injection site) had resolved. At the time of the report, RASH (Rash 3-4 times larger than the injection site, lumpy rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548473
Sex: F
Age:
State: AZ

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: I got tested positive for covid; Pain in arm; Fatigue, super tired; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got tested positive for covid), PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concomitant products included INSULIN ASPART (NOVOLOG), INSULIN DEGLUDEC (TRESIBA), BUSPIRONE, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), METOPROLOL and FLUDROCORTISONE for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired). On 06-Feb-2021, the patient experienced COVID-19 (I got tested positive for covid). At the time of the report, COVID-19 (I got tested positive for covid), PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: NOVOLOG; TRESIBA; BUSPIRONE; PAXIL [PAROXETINE HYDROCHLORIDE]; ADDERALL; METOPROLOL; FLUDROCORTISONE

Current Illness:

ID: 1548474
Sex: F
Age: 67
State: NC

Vax Date: 01/22/2021
Onset Date: 02/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Swelling in the joints of both her thumbs; Was very very ill; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was very very ill) and JOINT SWELLING (Swelling in the joints of both her thumbs) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 016M20A) for COVID-19 vaccination. Concurrent medical conditions included High cholesterol. Concomitant products included EZETIMIBE and SIMVASTATIN for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Was very very ill). On 21-Feb-2021, the patient experienced JOINT SWELLING (Swelling in the joints of both her thumbs). At the time of the report, MALAISE (Was very very ill) outcome was unknown and JOINT SWELLING (Swelling in the joints of both her thumbs) had resolved. Not Provided

Other Meds: EZETIMIBE; SIMVASTATIN

Current Illness: High cholesterol

ID: 1548475
Sex: F
Age: 69
State:

Vax Date: 01/21/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: every inch of her body was hurting; Nauseous; Chilled but not sweat; Terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache). On 19-Feb-2021, PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to US-MODERNATX, INC.-MOD-2021-017482 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2021-017482:same reporter , different patient.

Other Meds:

Current Illness:

ID: 1548476
Sex: F
Age: 68
State: NJ

Vax Date: 02/05/2021
Onset Date: 02/19/2020
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Rash on arm; red; bumpy; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on arm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2020, the patient experienced VACCINATION SITE PRURITUS (itchy). On 19-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash on arm), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy). At the time of the report, VACCINATION SITE RASH (Rash on arm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1548477
Sex: F
Age:
State: SD

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Cancelled second covid shot scheduled for 23feb2021; pain progressed to mid back; pain progressed to low back; Pain in her groin area; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GROIN PAIN (Pain in her groin area), BACK PAIN (pain progressed to low back), BACK PAIN (pain progressed to mid back) and INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042320A) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 27-Nov-2020 and Arrhythmia (NOS) (arrhythmias after having covid) from 15-Dec-2020 to 19-Feb-2021. Concurrent medical conditions included Drug allergy (blood pressure medications) and Drug allergy (aspirin). Concomitant products included CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D) and BIOTIN for Routine health maintenance. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced GROIN PAIN (Pain in her groin area). On 08-Feb-2021, the patient experienced BACK PAIN (pain progressed to low back). On 15-Feb-2021, the patient experienced BACK PAIN (pain progressed to mid back). On 19-Feb-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021). The patient was treated with METHYLPREDNISOLONE (METHYLPREDNISOLON [METHYLPREDNISOLONE]) at a dose of 1 dosage form and KETOROLAC TROMETHAMINE (TORADOL) at a dose of 1 dosage form. On 19-Feb-2021, INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021) had resolved. At the time of the report, GROIN PAIN (Pain in her groin area), BACK PAIN (pain progressed to low back) and BACK PAIN (pain progressed to mid back) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. Other concomitant product included Mukta Vati for blood pressure. On unknow date, Magnetic resonance imaging was performed and result was unknown. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: updated allergy, historical condition, concomitant medicationsadded one additional eventupdated events outcome from not recovered/resolved to recovered/resolved,

Other Meds: CALCIUM + VIT D; BIOTIN

Current Illness: Drug allergy (blood pressure medications)

ID: 1548478
Sex: F
Age: 82
State: RI

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: vaccine has something that improved her condition; Feels more aware overall; Significant cognitive improvement; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The patient's past medical history included Dementia. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement). At the time of the report, NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548479
Sex: M
Age: 67
State: AK

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PYREXIA (Temperature). At the time of the report, PYREXIA (Temperature) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1548480
Sex: M
Age: 72
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1548481
Sex: M
Age: 87
State: FL

Vax Date: 01/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. Concomitant products included RABEPRAZOLE SODIUM (ACIPHEX), METOPROLOL SUCCINATE (TOPROL), GABAPENTIN and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (Sore shoulder). On 11-Feb-2021, ARTHRALGIA (Sore shoulder) had resolved. Not Provided This case was linked to MOD-2021-017442 (Linked Report).; Sender's Comments: MOD-2021-017442:same reorter, different patient

Other Meds: ACIPHEX; TOPROL; GABAPENTIN; CRESTOR

Current Illness:

ID: 1548482
Sex: F
Age:
State: MI

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Rashes on her back; Rash on neck and little on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm). The patient was treated with XIPAMIDE (AQUAPHOR [XIPAMIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm) had resolved. No relevant concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up information received on 14-JUL-2021 and the outcome of the events has been updated from unknown to resolved.

Other Meds:

Current Illness:

ID: 1548483
Sex: F
Age:
State: MA

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Soreness of arm; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021. The most recent information was received on 14-Jul-2021 and was forwarded to Moderna on 14-Jul-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included Pain in arm (Patient stated she had the typical symptoms of a sore arm with any vaccine.). On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm). At the time of the report, PAIN IN EXTREMITY (Soreness of arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up information received on 14-Jul-2021 and included Newmedical history (typical symptoms of a sore arm with any vaccine) was added in patient medical history.

Other Meds:

Current Illness:

ID: 1548484
Sex: F
Age: 67
State: FL

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: rash came on the inside of her elbow on the other arm; rash on the arm of the shot, near the elbow on the underside of her arm; dizzy; trouble with acid reflux; lost of gas; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux), FLATULENCE (lost of gas), VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm) and RASH (rash came on the inside of her elbow on the other arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. Concomitant products included PROGESTERONE and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux) and FLATULENCE (lost of gas). On 14-Feb-2021, the patient experienced VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm). On 15-Feb-2021, the patient experienced RASH (rash came on the inside of her elbow on the other arm). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux), FLATULENCE (lost of gas) and VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm) outcome was unknown and RASH (rash came on the inside of her elbow on the other arm) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication include thyroid medication, implant with hormones. Treatment medication included diet.

Other Meds: SINGULAIR

Current Illness:

ID: 1548485
Sex: F
Age: 71
State: IL

Vax Date: 01/19/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: rapid heart rate; rash on entire torso; Felt tired; Low grade temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso), PYREXIA (Low grade temperature), CHILLS (Chills) and FATIGUE (Felt tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Heart beat abnormal neonatal. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (Low grade temperature) and CHILLS (Chills). On an unknown date, the patient experienced HEART RATE INCREASED (rapid heart rate) and FATIGUE (Felt tired). an unknown date, the patient experienced RASH (rash on entire torso). On 18-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso) and FATIGUE (Felt tired) outcome was unknown and PYREXIA (Low grade temperature) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 (High) low grade temperature 100.4 F. On an unknown date, Heart rate: 112 (Inconclusive) 112. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: additional event reported (rash on entire torso).

Other Meds: BABY ASPIRIN

Current Illness:

ID: 1548486
Sex: F
Age: 82
State: PA

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: woke up and she had extremely sore arm at the injection site; Warm to touch; Little itchy; and red at the injection site; Sore around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Little itchy), VACCINATION SITE ERYTHEMA (and red at the injection site) and VACCINATION SITE PAIN (Sore around the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 048A21A) for COVID-19 vaccination. Concurrent medical conditions included Hyperlipidemia. Concomitant products included RALOXIFENE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore around the injection site). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site), VACCINATION SITE WARMTH (Warm to touch) and VACCINATION SITE ERYTHEMA (and red at the injection site). 19-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Little itchy). At the time of the report, PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site) was resolving and VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Little itchy), VACCINATION SITE ERYTHEMA (and red at the injection site) and VACCINATION SITE PAIN (Sore around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication included Cholesterol medication Treatment medication were not provided. On 19-Feb-2021, the patient's arm was not as sore when she woke up,but it was still red, warm and little itchy The patient had no side effects after the second dose. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received on 28-APR-2021 contains non significant information:Address was updated. On 14-Jul-2021: Follow-up received on 14-JUL-2021 contains significant information: Batch number and route of administration for first dose updated.Second dose information updated.

Other Meds: RALOXIFENE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Hyperlipidemia

ID: 1548487
Sex: M
Age: 77
State: NE

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Has very low appetite; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired). On 20-Feb-2021, DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional info: TCR : updated events outcome from unknown to recovered.

Other Meds:

Current Illness:

ID: 1548488
Sex: F
Age: 94
State: NY

Vax Date: 01/20/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Lightheaded/ Dizziness; Chills; Slight soreness; A spontaneous report was received from a consumer concerning her mother, a 95-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events; slight soreness/pain, lightheadness/dizziness and chills. The patient's medical history was not provided. Concomitant medication list was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) on 20 Jan 2021 . On 17 Feb 2021 the patient received their second of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in an unspecified arm for the prophylaxis of COVID-19 infection. On 17 Feb 2021, after receiving mRNA-1273 the patient experienced slight soreness and chills. 48 hours later that is on 19 Feb 2021, the patient started feeling lightheaded and dizziness. It comes and goes but still happens everyday. Treatment provided for the events were not provided. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. The outcome of the events; slight soreness, lightheadnes/dizziness and chills was considered to be unknown. Follow up received on 26 Feb 2021include the event that occurred two days after second dose of mRNA-1273; dizziness/lightheadness.

Other Meds:

Current Illness:

ID: 1548489
Sex: F
Age: 81
State: IL

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: infection; left leg was swollen; left leg was sore; (sore leg) it woke her up a couple of times throughout the night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (left leg was sore), PERIPHERAL SWELLING (left leg was swollen), INFECTION (infection) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No medication history information was reported . Concomitant products included HYDROXYCARBAMIDE (HYDREA) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (left leg was sore) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night). On 13-Feb-2021, the patient experienced PERIPHERAL SWELLING (left leg was swollen). On 15-Feb-2021, the patient experienced INFECTION (infection). At the time of the report, PAIN IN EXTREMITY (left leg was sore), PERIPHERAL SWELLING (left leg was swollen), INFECTION (infection) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication include supplements. Treatment medication include antibiotics. Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 and contains no new information.

Other Meds: HYDREA; BABY ASPIRIN

Current Illness:

ID: 1548490
Sex: F
Age: 67
State: MI

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Site of injection feels worm; Site of injection has red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark). At the time of the report, VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was provided Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI

Other Meds:

Current Illness:

ID: 1548491
Sex: F
Age: 57
State: PA

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Loss of taste; Loss of smell; Sore arm; Light headed; Blurred vision; Weak knees; High BP (145); Swollen eyes; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included FENOFIBRATE, SERTRALINE, LOSARTAN and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)), EYE SWELLING (Swollen eyes) and PAIN IN EXTREMITY (Sore arm). On 11-Feb-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). On 08-Feb-2021, DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) had resolved. At the time of the report, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and PAIN IN EXTREMITY (Sore arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Blood pressure measurement: 145 High. On 16-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: FENOFIBRATE; SERTRALINE; LOSARTAN; LIPITOR

Current Illness:

ID: 1548492
Sex: F
Age: 94
State: NY

Vax Date: 01/20/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Slight soreness; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Slight soreness) and CHILLS (Chills) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Slight soreness) and CHILLS (Chills). At the time of the report, PAIN (Slight soreness) and CHILLS (Chills) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-017462 (Patient Link).

Other Meds:

Current Illness:

ID: 1548493
Sex: F
Age: 74
State: MN

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse reaction (No Medical history reported.). On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1548494
Sex: F
Age: 67
State: NC

Vax Date: 02/04/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: It burns; Rash on their upper back; It itches like crazy; Its red; Rash on the place where they got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ILM20A) for COVID-19 vaccination. No medical history reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine). At the time of the report, BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details included alcohol topical and some lotion. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1548495
Sex: F
Age: 59
State: NJ

Vax Date: 02/03/2021
Onset Date: 02/08/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No medical history reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1548496
Sex: F
Age:
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: A little soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No prior medical history was reported.). On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (A little soreness at the injection site). On 19-Feb-2021, VACCINATION SITE PAIN (A little soreness at the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information was not provided. The reporter wish to know whether she can have cocktail.

Other Meds:

Current Illness:

ID: 1548497
Sex: F
Age: 73
State: NC

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Headache; Neck Swelling (Sore throat); Neck Swelling (Sore throat); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. NO medical history reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)). At the time of the report, HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details included Advil.

Other Meds:

Current Illness:

ID: 1548498
Sex: M
Age: 67
State: FL

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Toes started having purple blothces; little minor achy; A spontaneous report was received from a consumer concerning a 67-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain (little minor achy) and skin discoloration ( toes started having purple blotches,looks like covid toe). The patient's medical history was not provided. Concomitant medications reported were Vitamin pill, Omeprazole for drug use for unknown indication. On 16 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031L20A) through unknown route in the left arm for prophylaxis of COVID-19 infection. On 16 Feb 2021, the patient experienced little minor achy. On 18 Feb 2021, the patient experienced toes that started having purple blotches and she stated it looks like Covid toe. Treatment details included None. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events was unknown.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1548499
Sex: F
Age: 39
State: NV

Vax Date: 02/03/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: diagnosed with an allergic reaction; left arm started itching at the injection site; left arm was also sore; rash kept growing; "full on rash"; arm became hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot). On 16-Feb-2021, the patient experienced HYPERSENSITIVITY (diagnosed with an allergic reaction). At the time of the report, VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash"), VACCINATION SITE WARMTH (arm became hot) and HYPERSENSITIVITY (diagnosed with an allergic reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details included triamcinolone acetonide cream USP 0.5 %, and oral methylprednisolone tablets USP 4 mg dose pack and Tylenol.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm